Holen Sie sich die Stockscreener-App
29.59
3.03%
0.87
Handel nachbörslich:
29.59
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HROW?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$28.72
Offen:
$29.01
24-Stunden-Volumen:
333.18K
Relative Volume:
0.61
Marktkapitalisierung:
$1.03B
Einnahmen:
$154.15M
Nettoeinkommen (Verlust:
$-33.58M
KGV:
-30.82
EPS:
-0.96
Netto-Cashflow:
$-20.74M
1W Leistung:
+5.27%
1M Leistung:
+22.68%
6M Leistung:
-24.75%
1J Leistung:
+64.76%
1-Tages-Spanne:
$28.96
$29.67
1-Wochen-Bereich:
$27.16
$30.28
52-Wochen-Spanne:
$16.87
$59.23
Harrow Inc Stock (HROW) Company Profile
Firmenname
Harrow Inc
Sektor
Telefon
615.733.4731
Adresse
1A BURTON HILLS BLVD, NASHVILLE, CA
Vergleichen Sie HROW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
29.59 | 1.03B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
170.16 | 75.08B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
11.07 | 51.07B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.96 | 46.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.77 | 19.24B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
325.82 | 14.38B | 2.99B | 1.21B | 1.13B | 25.06 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-04 | Bestätigt | B. Riley Securities | Buy |
| 2024-04-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-09-08 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-09-24 | Eingeleitet | Aegis Capital | Buy |
| 2021-07-02 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Harrow Inc Aktie (HROW) Neueste Nachrichten
Harrow Inc (HROW) Shares Down 5.39% on Jun 5 - GuruFocus
B. Riley Issues Pessimistic Forecast for Harrow Earnings - Defense World
Insiders Favor Harrow And 2 Other Leading Growth Companies - Yahoo Finance
Harrow Inc (HROW) Shares Up 4.04% on May 30 - GuruFocus
Obituary for Douglas "Doug" A. Harrow - Schaffer Funeral Home, Inc.
Harrow: Epic Growth & Operating Leverage On Full Display (NASDAQ:HROW) - Seeking Alpha
Harrow Inc (HROW) Stock Price Down 3.78% on May 22 - GuruFocus
Deutsche Bank AG Has $3.63 Million Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World
The Manufacturers Life Insurance Company Has $372,000 Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow Inc (HROW) Stock Price Up 8.35% on May 16 - GuruFocus
Harrow Inc.: Opaleye management sells $150,055 in stock - Investing.com Australia
Harrow Inc.: Opaleye management sells $150,055 in stock By Investing.com - Investing.com India
Jim Cramer on Harrow, Inc. (HROW) – “Eye Care’s a Good Biz – If It Makes Money, Don’t Walk Away Pre-Breakout” - Insider Monkey
Harrow to Present at Two Investor Conferences in May - Business Wire
Jim Cramer Is 'OK' With Harrow, Recommends Buying This Energy Stock - Benzinga
Harrow Health, Inc. (NASDAQ:HROW) Q1 2025 Earnings Call Transcript - Insider Monkey
Harrow (HROW) Faces Price Target Cut Amid Q1 Earnings Miss | HRO - GuruFocus
HROW Stock Price Target Raised to $60 by Analyst | HROW Stock Ne - GuruFocus
Price T Rowe Associates Inc. MD Buys 1,428 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow (NASDAQ:HROW) Price Target Raised to $60.00 at HC Wainwright - Defense World
Where Harrow Stands With Analysts - Benzinga
HROW Stock Update: Analyst Raises Price Target to $60 | HROW Sto - GuruFocus
HROW Stock Price Target Raised to $60 by Analyst | HROW Stock News - GuruFocus
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates - MSN
Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... - Yahoo Finance
Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Market Expansions - GuruFocus
Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Reven - GuruFocus
Harrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... By GuruFocus - Investing.com Canada
Harrow Health Reports Strong Q1 2025 Revenue Growth - TipRanks
Harrow Announces First-Quarter 2025 Financial Results - BioSpace
Transcript : Harrow, Inc., Q1 2025 Earnings Call, May 09, 2025 - marketscreener.com
Harrow Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Harrow: Q1 Earnings Snapshot - CT Insider
Harrow Health Q1 2025 slides: revenue up 43% as ophthalmic portfolio expands - Investing.com
Harrow Health (HROW) Reports Q1 Revenue Miss Despite Growth - GuruFocus
Harrow Inc (HROW) Q1 2025 Earnings: EPS of -$0.50 Misses Estimate, Revenue at $47.8M Below Forecast - GuruFocus
Earnings Flash (HROW) HARROW INC. Reports Q1 Loss $0.38 Per Share - marketscreener.com
Harrow (HROW) Sees Promising Revenue Growth and Expansion Plans | HROW Stock News - GuruFocus
HROW Forecasts Surpassing $280 Million Revenue by 2025 | HROW St - GuruFocus
HROW Forecasts Surpassing $280 Million Revenue by 2025 | HROW Stock News - GuruFocus
Harrow Inc (HROW) Q1 2025 Earnings Report Preview: What to Look For - GuruFocus
Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025 | HROW Stock News - GuruFocus
Examining the Future: Harrow's Earnings Outlook - Nasdaq
What To Expect From Harrow Inc (HROW) Q1 2025 Earnings - Yahoo Finance
Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025 - Business Wire
Finanzdaten der Harrow Inc-Aktie (HROW)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):